Expanded Access for ATB200/AT2221 for the Treatment of Pompe Disease
NCT03865836 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-09-15
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to ATB200/AT2221.
Conditions
- Pompe Disease
Interventions
- BIOLOGICAL
-
ATB200
- DRUG
-
AT2221
Sponsors & Collaborators
-
Amicus Therapeutics
lead INDUSTRY
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation
NCT00785902 ·Status: WITHDRAWN ·Phase: PHASE3
-
Convergent Ablation Plus Left Atrial Appendage Isolation for the Treatment of Persistent Atrial Fibrillation
NCT06165510 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
NCT00971204 ·Status: COMPLETED ·Phase: PHASE2
-
AtriCure Bipolar Radiofrequency Ablation of Permanent Atrial Fibrillation
NCT00560885 ·Status: COMPLETED ·Phase: PHASE3
-
AF Substrate Mapping and Guided Ablation
NCT02571218 ·Status: COMPLETED ·Phase: NA
-
Stroke Feasibility Study
NCT01997905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SAVEPACe - Search AV Extension and Managed Ventricular Pacing for Promoting Atrio-Ventricular Conduction
NCT00284830 ·Status: COMPLETED ·Phase: NA
-
Amplify EP Registry
NCT06669637 ·Status: NOT_YET_RECRUITING
-
Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation
NCT00196183 ·Status: COMPLETED ·Phase: PHASE4
-
Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study
NCT03854149 ·Status: COMPLETED
-
Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation
NCT05889208 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
MultiPulse Therapy (MPT) for AF (US)
NCT05055921 ·Status: TERMINATED ·Phase: NA
-
CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)
NCT01984346 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation
NCT03650556 ·Status: COMPLETED ·Phase: NA
-
Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation
NCT02008448 ·Status: UNKNOWN ·Phase: PHASE2
-
Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.
NCT04780438 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
CONVERGE Post-Approval Study (PAS)
NCT05393180 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
NCT00129545 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
IMPULSE: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation
NCT03700385 ·Status: COMPLETED ·Phase: NA
-
A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator
NCT05971693 ·Status: COMPLETED ·Phase: NA
-
AMPLATZER Cardiac Plug Clinical Trial
NCT01118299 ·Status: COMPLETED ·Phase: NA
-
AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB
NCT00571779 ·Status: WITHDRAWN ·Phase: PHASE2
-
Feasibility Study of the FARAPULSE Endocardial Multi Ablation System in the Treatment of Persistent Atrial Fibrillation
NCT04170621 ·Status: COMPLETED ·Phase: NA
-
AF Burden and Echo-guided Persistent AF Ablation Strategy Using Either PV Isolation Alone (CLOSE Protocol) or Optimized Compartmentalization of the Left Atrium (Pseudo-maze Technique)
NCT04773119 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment
NCT02834221 ·Status: COMPLETED ·Phase: NA